Grovet is moving! Due to the relocating, we will be closed from until May 31 2024. No orders will be processed or shipped during this period. However, it is possible to place your order. Orders will be processed again from June 3 2024, please allow for some delay. More information about the relocating, you can find here.
SUMMIT- We are excited to announce that the Equine Regenerative Summit is returning with new content from Oktober 2022!
The 2022 Equine Regenerative Medicine & Orthobiologics online SUMMIT. Capturing the most current scientific and clinical information regarding the use of orthobiologics in Human, Canine en Equine atheletes.
20% discount full program price for customers use code GROERMOS22 at registration! Sign up for SUMMIT
* This program is accredited for 22,5 CE points.
New at Grovet: HorStem
Since the 1st of September, Grovet has been the distributor of Horstem in the Netherlands, Germany and Poland. Horstem is the first registered veterinary medicine that consists of stem cells obtained from the umbilical cord of horses. These stem cells reduce lameness in horses with chronic inflammation of the joints (osteoarthritis). Horstem is ready-to-use, it can be injected directly into the affected joint.
In horses with osteoarthritis, Horstem inhibits the inflammatory response and the breakdown of cartilage. This reduces the horse's lameness and the clinical results last for more than a year.
Other advantages of stem cells obtained from the umbilical cord include:
· The cells are obtained non-invasively from birth tissue after birth.
